1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and validation of a clinical-grade cell-free DNA profiling assay: MSK-ACCESS
    Meeting Abstract

    Tsui, D. W. Y.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Improved progression-free and overall survival (PFS/OS) in patients (pts) with emergence of JTX-2011 associated biomarker (ICOS high CD4 T cells) on the ICONIC trial
    Meeting Abstract

    Yap, T. A.; Gainor, J. F.; Callahan, M. K.; Falchook, G. S.; Pachynski, R. K.; LoRusso, P.; Kummar, S.; Gibney, G. T.; Burris, H. A.; Tykodi, S. S.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple on-target resistance mechanisms: Results from the SUMMIT "Basket" Trial
    Meeting Abstract

    Won, H. H.; Selcuklu, S. D.; Piha-Paul, S. A.; Saura, C.; Rodon, J.; Mayer, I. A.; Loi, S.; Shapiro, G. I.; Lu, J.; Brufsky, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hyperactivation of mTORC1 drives acquired resistance to the pan -HER tyrosine kinase inhibitor neratinib in HER2-mutant cancers
    Meeting Abstract

    Sudhan, D. R.; Guerrero-Zotano, A.; Won, H.; Ericsson, P. G.; Liu, Q.; Dugger, T.; Koch, J.; Schram, A.; Servetto, A.; Cutler, R.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The Polycomb repressor complex 1 promotes recruitment of myeloid-derived suppressor cells and immune evasion during bone colonization in castration-resistant prostate cancer
    Meeting Abstract

    Su, W.; Zhang, B.; Han, H.; Chakraborty, G.; Zhou, B.; Su, J.; Yang, G.; Ouerfelli, O.; Rosen, N.; Scher, H. I.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Enhancing apoptosis to improve the therapy of EGFR-mutant lung cancer
    Meeting Abstract

    Tanaka, K.; Han, S.; Ganesan, Y. T.; Hsieh, J. J.; Cheng, E. H.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • ARAF activates RAS by antagonizing its interaction with NF1
    Meeting Abstract

    Su, W.; Yaeger, R.; Na, N.; Hechtman, J.; Paroder, V.; Misale, S.; Han, S. W.; Abdel-Wahab, O. I.; McCormick, F.; Rosen, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • ARID1A is a critical regulator of luminal identity and therapeutic response in estrogen receptor-positive breast cancer
    Meeting Abstract

    Toska, E.; Xu, G.; Chhangawala, S.; Cocco, E.; Razavi, P.; Otto, J.; Cai, Y.; Chan, C.; D'Avino, D. R.; Collings, C.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium
    Meeting Abstract

    Sasamoto, N.; Babic, A.; Jordan, S.; Risch, H.; Harris, H.; Rossing, M. A.; Doherty, J.; Goodman, M.; Thompson, P.; Kjær, S. K.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Predictive biomarkers in circulating tumor cells to direct management metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Scher, H. I.; Schonhoft, J.; Dittamore, R.
    Cancer Research (2019)

    Fulltext@MSK | Save